Safety, adverse events, and how they factor into which medication may be right for you Common side effects of semaglutide and tirzepatide include: Nausea Vomiting Diarrhea Stomach pain Decreased appetite Indigestion Belching Constipation Headache Risk of low blood sugar Semaglutide and tirzepatide can cause serious side effects such as pancreatitis (inflammation of the pancreas), gallbladder problems, changes in vision, serious allergic reactions, and kidney issues

Injection Technique Best Practices Proper subcutaneous injection technique for cagrilintide follows these steps: Preparation Allow refrigerated peptide to reach room temperature (15-30 minutes) Hygiene Wash hands thoroughly and clean injection site with alcohol swab Pinch technique Gently pinch skin to create a fold of subcutaneous tissue Insertion angle Insert needle at 45-90 degree angle depending on subcutaneous fat thickness Injection Depress plunger slowly and steadily over 5-10 seconds Withdrawal Wait 5 seconds after full depression, then withdraw needle smoothly Pressure Apply gentle pressure with clean gauze if needed (do not rub) For researchers working with peptide administration protocols, these techniques ensure consistent delivery and reproducible results
Alzheimer's & Dementia (2025)
The cirrhosis caused by NASH can raise the risk of other severe complications, including hepatocellular carcinoma (the most common form of primary liver cancer) and outright liver failure
Others provide the right texture and digestibility for a stomach that empties slowly
Adverse effects GLP-1RAs are generally well tolerated, but with a common set of side effects, typically affecting the gastrointestinal system